---
$id: https://graph.org.ai/products/commodity/51152043
$type: Product
source: UNSPSC
code: "51152043"
title: "Promoxolane"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Promoxolane

**UNSPSC Code**: 51152043
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a muscle relaxant with the molecular formula C10H20O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JHI9RRY52E, chemically known as 2,2-diisopropyl-4-methanol-1,3-dioxolane but generally known as promoxolane, which bears US NIH Compound Identifier 10105. European Medicines Agency schedules Promoxolane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10091MIG. The term PROMOXOLANE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). PROMOXOLANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule promoxolane under HS 29329970 and SITC 51569. As of Q4 2014, PROMOXOLANE remains the US FDA Preferred Term for this commodity. Promoxolane bears US NLM identifiers UMLS ID C0520813 and NCI Concept Code C82296. SMILES: CC(C)C1(OCC(O1)CO)C(C)C.

